戻る Agendas
DIAGNOSTIC AND PHARMACODYNAMIC BIOMARKERS AND MASS SPECTROMETRY ASSAYS THEREOF: CURRENT STATUS AND PERSPECTIVES
Session Chair(s)
Pierre Marquet, DrMed, PHD
Professor of Clinical Pharmacology
University of Limoges, France
Proteomics, peptidomics and metabolomics are considered to be sources of potential biomarkers of disease or drug response in many clinical areas, including organ transplantation and such biomarkers are already well advanced towards clinical practice. In this session we will present examples of protein, lipid and metabolite biomarkers, together with the mass spectrometry assays involved; the regulatory paths for approval of biomarkers, as well as mass spectrometry assays in Europe.
Speaker(s)
Protein and Metabolite Biomarkers of Graft Injuries in Renal Transplantation
Pierre Marquet, DrMed, PHD
University of Limoges, France
Professor of Clinical Pharmacology
Mass Spectrometry as a Routine Clinical Diagnostic Technique
Olof Beck
Karolinska Institute, Sweden
Adjunct Professor, Division of Clinical Pharmacology
Regulatory Issues in Clinical Biomarkers and Mass Spectrometry Assays in Europe
Harald Mischak
University of Glasgow, United Kingdom
Institute of Cardiovascular and Medical Sciences